Avoid Methotrexate 50mg/m² if you have pre-existing significant liver or kidney disease. Patients with bone marrow suppression require careful monitoring and dose adjustment.
Pregnant or breastfeeding individuals should absolutely not use Methotrexate. Reliable contraception is mandatory during treatment and for at least three months after.
Severe, active infections warrant postponement of treatment until resolution. Monitor for signs of infection vigilantly throughout therapy.
Assess for peptic ulcers or gastrointestinal bleeding before starting treatment. Methotrexate can exacerbate these conditions. Consider prophylactic measures if needed.
Regular monitoring of complete blood count (CBC) and liver function tests (LFTs) is crucial to detect potential adverse effects. Adjust the dosage based on these results.
Patients with pre-existing pulmonary disease should be carefully evaluated before Methotrexate initiation. Respiratory complications are a potential adverse event.
Inform your physician about all medications you are taking, including over-the-counter drugs and herbal supplements. Many medications interact with Methotrexate.
Report any unusual bleeding, bruising, fatigue, or persistent nausea or vomiting to your doctor immediately. These can be signs of serious side effects.
Hydration is important to minimize kidney toxicity. Encourage adequate fluid intake during treatment.
Always follow your physician’s instructions precisely regarding dosage and administration. Improper use may lead to serious complications.
